Shanghai, China

Yali Wang

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Wuxi Grandchamp Pharmaceutical Technology Co., Ltd.. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yali Wang. Retrieved from https://idiyas.com/inventor/yali-wang-wh8ja599

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

 

 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 34(Granted Patents)


Location History:

  • Jiangsu, CN (2012 - 2014)
  • Markham, CA (2014)
  • Shanghai, CN (2016 - 2020)
  • Lianyungang, CN (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Yali Wang: Innovator in Pharmaceutical Science

Introduction

Yali Wang is a prominent inventor based in Shanghai, China, known for his significant contributions to pharmaceutical science. With a total of 8 patents, he has made remarkable advancements in the field of drug development, particularly in insulin analogues and cancer treatment.

Latest Patents

One of Yali Wang's latest patents is the "Acylated derivative of human insulin or analogue thereof." This invention provides an acylated derivative of human insulin or an analogue, specifically focusing on a human insulin analogue that is derivatized, preferably Des(B30) human insulin. The acylated derivative is designed to be longer-lasting than existing insulin analogues, offering a more stable blood glucose reduction and improved storage stability. Another notable patent is the "Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof." This invention details a ligand-cytotoxic drug conjugate that can be utilized in cancer treatment through receptor modulation, showcasing Wang's innovative approach to addressing complex medical challenges.

Career Highlights

Yali Wang has worked with reputable companies such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of medical science.

Collaborations

Throughout his career, Yali Wang has collaborated with notable colleagues, including Changan Sun and Lianshan Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yali Wang's contributions to pharmaceutical science through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to impact the field positively, paving the way for future advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…